« Intel Gets into the Healthcare Business with New Caregiving Site | Main | Marketing to Boomers: Don't Stereotype. »

June 30, 2008

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341ee07753ef00e5537cc4828833

Listed below are links to weblogs that reference Follow-Up: Wyeth Alzheimer's Drug Fails to Meet Goal in Trial :

Comments

A new Alzheimer's treatment has been developed called Memeron utilizing Galantamine Hydrobromide and choline alphoscerate. See http://www.memeron.com

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Enter your email address:

Delivered by FeedBurner

AddThis Social Bookmark Button

Blogroll

Blog powered by TypePad